Beam Therapeutics Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
BEAM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
26 Landsdowne Street, Cambridge, MA

Insiders trading volume in the past year

Beam Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ARCH Venture Partners IX, LLC 10%+ Owner $77.9M Jun 30, 2021
Kristina Burow Director $73M Jun 6, 2023
Fmr Llc Other*, 10%+ Owner $63.3M -$992K -1.54% Jul 30, 2025
John M. Evans CEO, Director $30.3M -$1.79M -5.58% Oct 1, 2025
Giuseppe Ciaramella President $5.2M -$2.83M -35.2% Apr 1, 2025
Sravan K. Emany Chief Financial Officer $3.96M Dec 31, 2024
Terry-Ann Burrell Chief Financial Officer $3.13M Apr 26, 2024
Christine Bellon Chief Legal Officer $3.12M -$484K -13.4% Oct 1, 2025
Amy Simon Chief Medical Officer $2.65M -$572K -17.8% Jul 1, 2025
Bethany J. Cavanagh SVP, Finance and Treasurer $1.57M -$314K -16.7% Oct 1, 2025
Chirfi Guindo Director $954K Jun 4, 2025
John Maraganore Director $564K Jun 4, 2025
Graham K. Cooper Director $564K Jun 4, 2025
Mark Fishman Director $564K Jun 4, 2025
Christi Shaw Director $564K Jun 4, 2025
Carole Ho Director $564K Jun 4, 2025
Kathleen E. Walsh Director $403K Jun 4, 2025

Recent Insider Transactions by Companies or Individuals for Beam Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.